Emerald Health Preparing for Phase 2 Trial of EHP-101 for Relapsing MS & Lemtrada Journey

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Emerald Health is preparing for phase 2 trial of EHP-101 for relapsing forms of MS.

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads “An Update on My Lemtrada Journey 3 Years After Round 2”, a column by Ed Tobias.

=====================================

Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud

=====================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/